Patents by Inventor Jelka Svetek

Jelka Svetek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8648175
    Abstract: The present invention provides a new stable pharmaceutical composition of erythropoietin (EPO) that is stabilized with PVP.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: February 11, 2014
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Andreja Vukmirovic, Tanja Rozman Peterka, Jelka Svetek, Alenka Paris
  • Patent number: 7534870
    Abstract: The present invention provides a new stable pharmaceutical composition of erythropoietin (EPO) that is stabilized with a combination of a poloxamer polyol and a polyhydric alcohol.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: May 19, 2009
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Andreja Vukmirovic, Tanja Rozman Peterka, Jelka Svetek, Alenka Paris
  • Publication number: 20050238720
    Abstract: The present invention provides a new stable pharmaceutical composition of erythropoietin (EPO) that is stabilized with PVP.
    Type: Application
    Filed: November 8, 2002
    Publication date: October 27, 2005
    Inventors: Andreja Vukmirovic, Tanja Peterka, Jelka Svetek, Alenka Paris
  • Publication number: 20050202091
    Abstract: The present invention provides a new stable pharmaceutical composition of erythropoietin (EPO) that is stabilized with a combination of a poloxamer polyol and a polyhydric alcohol.
    Type: Application
    Filed: July 14, 2003
    Publication date: September 15, 2005
    Inventors: Andreja Vukmirovic, Tanja Rozman Peterka, Jelka Svetek, Alenka Paris
  • Publication number: 20050153879
    Abstract: The present invention provides a process for the production of erythropoietin (EPO) with high purity and with a desired profile of EPO glycol-isoforms by using a combination of specific chromatographic steps in such a manner that the starting EPO glycol-isoform profile is changed or modified. The applied chromatographic steps includes at least (a) dye affinity chromatography, and (b) hydrophobic chromatography and/or (c) anion-exchange chromatography. In a preferred embodiment, the process further includes (d) gel filtration chromatography. The present invention also provides a process for the determination of erythropoietin (EPO) glycol-isoform profile in an EPO containing composition.
    Type: Application
    Filed: March 26, 2002
    Publication date: July 14, 2005
    Inventors: Monica Svetina, Jelka Svetek, Mateja Gantar-Ksela, Matjaz Brinc, Andrej Francky